株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

自己免疫疾患治療薬の世界市場

Autoimmune Disease Therapeutics

発行 Global Industry Analysts, Inc. 商品コード 912537
出版日 ページ情報 英文 259 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.06円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
自己免疫疾患治療薬の世界市場 Autoimmune Disease Therapeutics
出版日: 2019年10月01日 ページ情報: 英文 259 Pages
概要

当レポートでは、世界の自己免疫疾患治療薬の市場を調査し、市場の定義と概要、市場動向・市場成長への各種影響因子の分析、競合企業と市場シェア、世界および地域・主要国別の市場規模の推移と予測、各種区分別の内訳、主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界の企業シェア
    • 企業シェアシナリオ:実績・予測
  • 主要企業
  • 市場動向・成長推進因子
  • 世界市場の展望:市場規模・市場シェアの推移・予測
    • 薬剤クラス別
    • 抗炎症薬
    • 血糖降下薬
    • NSAID (非ステロイド性抗炎症薬)
    • インターフェロン
    • その他
    • 適応症別
    • リウマチ性疾患
    • I型糖尿病
    • 多発性硬化症
    • 炎症性腸疾患
    • その他

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他
  • アジア太平洋
    • オーストラリア
    • インド
    • 韓国
    • その他
  • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • メキシコ
    • その他
  • 中東
    • イラン
    • イスラエル
    • サウジアラビア
    • UAE
    • その他
  • アフリカ

第4章 競合企業

  • ABBOTT LABORATORIES
  • ABBVIE
  • AMGEN
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON & JOHNSON
  • NOVARTIS INTERNATIONAL AG
  • PFIZER
  • UCB SA

第5章 調査資料

目次
Product Code: MCP-1829

Autoimmune Disease Therapeutics market worldwide is projected to grow by US$36 Billion, driven by a compounded growth of 4.1%. Anti-inflammatory, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$79.1 Billion by the year 2025, Anti-inflammatory will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.3 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.1 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Anti-inflammatory will reach a market size of US$4.6 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.4% over the next couple of years and add approximately US$10.2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Abbott Laboratories, Inc.; AbbVie, Inc.; Amgen, Inc.; AstraZeneca PLC; Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis International AG; Pfizer, Inc.; UCB SA

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Autoimmune Disease Therapeutics Competitor Market Share Scenario Worldwide (in %):
  • 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

    • TABLE 1: Autoimmune Disease Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 2: Autoimmune Disease Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
    • TABLE 3: Autoimmune Disease Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
    • TABLE 4: Anti-inflammatory (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
    • TABLE 5: Anti-inflammatory (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
    • TABLE 6: Anti-inflammatory (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 7: Antihyperglycemics (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
    • TABLE 8: Antihyperglycemics (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
    • TABLE 9: Antihyperglycemics (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
    • TABLE 10: NSAIDs (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
    • TABLE 11: NSAIDs (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
    • TABLE 12: NSAIDs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 13: Interferons (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
    • TABLE 14: Interferons (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
    • TABLE 15: Interferons (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 16: Other Drug Class (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
    • TABLE 17: Other Drug Class (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
    • TABLE 18: Other Drug Class (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 19: Rheumatic Disease (Indication) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
    • TABLE 20: Rheumatic Disease (Indication) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
    • TABLE 21: Rheumatic Disease (Indication) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 22: Type 1 Diabetes (Indication) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
    • TABLE 23: Type 1 Diabetes (Indication) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
    • TABLE 24: Type 1 Diabetes (Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 25: Multiple Sclerosis (Indication) World Market by Region/Country in US$ Million:
    • 2018 to 2025
    • TABLE 26: Multiple Sclerosis (Indication) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
    • TABLE 27: Multiple Sclerosis (Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 28: Inflammatory Bowel Disease (Indication) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
    • TABLE 29: Inflammatory Bowel Disease (Indication) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
    • TABLE 30: Inflammatory Bowel Disease (Indication) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
    • TABLE 31: Other Indications (Indication) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
    • TABLE 32: Other Indications (Indication) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
    • TABLE 33: Other Indications (Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Autoimmune Disease Therapeutics Market Share (in %) by Company: 2019 & 2025
    • TABLE 34: United States Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 35: Autoimmune Disease Therapeutics Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 36: United States Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 37: United States Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Indication: 2018 to 2025
    • TABLE 38: Autoimmune Disease Therapeutics Market in the United States by Indication: A Historic Review in US$ Million for 2009-2017
    • TABLE 39: United States Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 40: Canadian Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 41: Canadian Autoimmune Disease Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 42: Autoimmune Disease Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 43: Canadian Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
    • TABLE 44: Canadian Autoimmune Disease Therapeutics Historic Market Review by Indication in US$ Million: 2009-2017
    • TABLE 45: Autoimmune Disease Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
  • JAPAN
    • TABLE 46: Japanese Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 47: Autoimmune Disease Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 48: Japanese Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 49: Japanese Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
    • TABLE 50: Autoimmune Disease Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
    • TABLE 51: Japanese Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 52: Chinese Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 53: Autoimmune Disease Therapeutics Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017
    • TABLE 54: Chinese Autoimmune Disease Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 55: Chinese Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
    • TABLE 56: Autoimmune Disease Therapeutics Historic Market Analysis in China in US$ Million by Indication: 2009-2017
    • TABLE 57: Chinese Autoimmune Disease Therapeutics Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Autoimmune Disease Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 58: European Autoimmune Disease Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 59: Autoimmune Disease Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 60: European Autoimmune Disease Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 61: European Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 62: Autoimmune Disease Therapeutics Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 63: European Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 64: European Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
    • TABLE 65: Autoimmune Disease Therapeutics Market in Europe in US$ Million by Indication: A Historic Review for the Period 2009-2017
    • TABLE 66: European Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 67: Autoimmune Disease Therapeutics Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 68: French Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 69: French Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 70: Autoimmune Disease Therapeutics Market in France by Indication: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 71: French Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Indication: 2009-2017
    • TABLE 72: French Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 73: Autoimmune Disease Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 74: German Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 75: German Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 76: Autoimmune Disease Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 77: German Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 78: German Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 79: Italian Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 80: Autoimmune Disease Therapeutics Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017
    • TABLE 81: Italian Autoimmune Disease Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 82: Italian Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
    • TABLE 83: Autoimmune Disease Therapeutics Historic Market Analysis in Italy in US$ Million by Indication: 2009-2017
    • TABLE 84: Italian Autoimmune Disease Therapeutics Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 85: United Kingdom Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 86: Autoimmune Disease Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 87: United Kingdom Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 88: United Kingdom Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
    • TABLE 89: Autoimmune Disease Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
    • TABLE 90: United Kingdom Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 91: Spanish Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 92: Spanish Autoimmune Disease Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 93: Autoimmune Disease Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 94: Spanish Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
    • TABLE 95: Spanish Autoimmune Disease Therapeutics Historic Market Review by Indication in US$ Million: 2009-2017
    • TABLE 96: Autoimmune Disease Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 97: Russian Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 98: Autoimmune Disease Therapeutics Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 99: Russian Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 100: Russian Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Indication: 2018 to 2025
    • TABLE 101: Autoimmune Disease Therapeutics Market in Russia by Indication: A Historic Review in US$ Million for 2009-2017
    • TABLE 102: Russian Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 103: Rest of Europe Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 104: Autoimmune Disease Therapeutics Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 105: Rest of Europe Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 106: Rest of Europe Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
    • TABLE 107: Autoimmune Disease Therapeutics Market in Rest of Europe in US$ Million by Indication: A Historic Review for the Period 2009-2017
    • TABLE 108: Rest of Europe Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 109: Asia-Pacific Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 110: Autoimmune Disease Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 111: Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 112: Autoimmune Disease Therapeutics Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 113: Asia-Pacific Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 114: Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 115: Autoimmune Disease Therapeutics Market in Asia-Pacific by Indication: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 116: Asia-Pacific Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Indication: 2009-2017
    • TABLE 117: Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 118: Autoimmune Disease Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 119: Australian Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 120: Australian Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 121: Autoimmune Disease Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 122: Australian Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 123: Australian Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 124: Indian Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 125: Indian Autoimmune Disease Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 126: Autoimmune Disease Therapeutics Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 127: Indian Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
    • TABLE 128: Indian Autoimmune Disease Therapeutics Historic Market Review by Indication in US$ Million: 2009-2017
    • TABLE 129: Autoimmune Disease Therapeutics Market in India: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 130: Autoimmune Disease Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 131: South Korean Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 132: Autoimmune Disease Therapeutics Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 133: Autoimmune Disease Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 134: South Korean Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 135: Autoimmune Disease Therapeutics Market Share Distribution in South Korea by Indication: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 136: Rest of Asia-Pacific Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 137: Autoimmune Disease Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 138: Rest of Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 139: Rest of Asia-Pacific Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
    • TABLE 140: Autoimmune Disease Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
    • TABLE 141: Rest of Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 142: Latin American Autoimmune Disease Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 143: Autoimmune Disease Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 144: Latin American Autoimmune Disease Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 145: Latin American Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 146: Autoimmune Disease Therapeutics Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017
    • TABLE 147: Latin American Autoimmune Disease Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 148: Latin American Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
    • TABLE 149: Autoimmune Disease Therapeutics Historic Market Analysis in Latin America in US$ Million by Indication: 2009-2017
    • TABLE 150: Latin American Autoimmune Disease Therapeutics Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 151: Argentinean Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 152: Autoimmune Disease Therapeutics Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 153: Argentinean Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 154: Argentinean Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
    • TABLE 155: Autoimmune Disease Therapeutics Market in Argentina in US$ Million by Indication: A Historic Review for the Period 2009-2017
    • TABLE 156: Argentinean Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 157: Autoimmune Disease Therapeutics Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 158: Brazilian Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 159: Brazilian Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 160: Autoimmune Disease Therapeutics Market in Brazil by Indication: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 161: Brazilian Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Indication: 2009-2017
    • TABLE 162: Brazilian Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 163: Autoimmune Disease Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 164: Mexican Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 165: Mexican Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 166: Autoimmune Disease Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 167: Mexican Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 168: Mexican Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 169: Rest of Latin America Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 170: Autoimmune Disease Therapeutics Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 171: Rest of Latin America Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 172: Rest of Latin America Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Indication: 2018 to 2025
    • TABLE 173: Autoimmune Disease Therapeutics Market in Rest of Latin America by Indication: A Historic Review in US$ Million for 2009-2017
    • TABLE 174: Rest of Latin America Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 175: The Middle East Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 176: Autoimmune Disease Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 177: The Middle East Autoimmune Disease Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 178: The Middle East Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 179: The Middle East Autoimmune Disease Therapeutics Historic Market by Drug Class in US$ Million: 2009-2017
    • TABLE 180: Autoimmune Disease Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 181: The Middle East Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
    • TABLE 182: The Middle East Autoimmune Disease Therapeutics Historic Market by Indication in US$ Million: 2009-2017
    • TABLE 183: Autoimmune Disease Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
  • IRAN
    • TABLE 184: Iranian Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 185: Autoimmune Disease Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 186: Iranian Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 187: Iranian Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
    • TABLE 188: Autoimmune Disease Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
    • TABLE 189: Iranian Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 190: Israeli Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 191: Autoimmune Disease Therapeutics Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 192: Israeli Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 193: Israeli Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
    • TABLE 194: Autoimmune Disease Therapeutics Market in Israel in US$ Million by Indication: A Historic Review for the Period 2009-2017
    • TABLE 195: Israeli Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 196: Saudi Arabian Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 197: Autoimmune Disease Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017
    • TABLE 198: Saudi Arabian Autoimmune Disease Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 199: Saudi Arabian Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
    • TABLE 200: Autoimmune Disease Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Indication: 2009-2017
    • TABLE 201: Saudi Arabian Autoimmune Disease Therapeutics Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 202: Autoimmune Disease Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 203: United Arab Emirates Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 204: Autoimmune Disease Therapeutics Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 205: Autoimmune Disease Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 206: United Arab Emirates Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 207: Autoimmune Disease Therapeutics Market Share Distribution in United Arab Emirates by Indication: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 208: Autoimmune Disease Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 209: Rest of Middle East Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 210: Rest of Middle East Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 211: Autoimmune Disease Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 212: Rest of Middle East Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 213: Rest of Middle East Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 214: African Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 215: Autoimmune Disease Therapeutics Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 216: African Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 217: African Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Indication: 2018 to 2025
    • TABLE 218: Autoimmune Disease Therapeutics Market in Africa by Indication: A Historic Review in US$ Million for 2009-2017
    • TABLE 219: African Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBOTT LABORATORIES
  • ABBVIE
  • AMGEN
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON & JOHNSON
  • NOVARTIS INTERNATIONAL AG
  • PFIZER
  • UCB SA

V. CURATED RESEARCH

Back to Top